Tag Archives: Bempedoic Acid

Esperion Sets Phase 2 Study Of Cholesterol Buster Combo

ANN ARBOR — Esperion Therapeutics Inc. (NASDAQ:ESPR), the Ann Arbor-based pharmaceutical startup, announced the initiation of a Phase 2 clinical study (1002-039) to assess the efficacy and safety of its drug candidate, bempedoic acid, in addition to another form of injectable cholesterol-fighter.

Continue reading Esperion Sets Phase 2 Study Of Cholesterol Buster Combo

Esperion Provides Drug Development Update, Financial Results

ANN ARBOR — Esperion Therapeutics Inc. (NASDAQ:ESPR), the pharmaceutical startup working on a new class of cholesterol-reducing drugs, provided a drug development update and financial results for 2016.

Continue reading Esperion Provides Drug Development Update, Financial Results